103 related articles for article (PubMed ID: 15880094)
1. Enhancement of gene delivery to cancer cells by a retargeted adenovirus.
Oh KS; Engler JA; Joung I
J Microbiol; 2005 Apr; 43(2):179-82. PubMed ID: 15880094
[TBL] [Abstract][Full Text] [Related]
2. Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector.
Joung I; Harber G; Gerecke KM; Carroll SL; Collawn JF; Engler JA
Biochem Biophys Res Commun; 2005 Mar; 328(4):1182-7. PubMed ID: 15708001
[TBL] [Abstract][Full Text] [Related]
3. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
4. Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy.
Høgset A; Engesaeter BO; Prasmickaite L; Berg K; Fodstad O; Maelandsmo GM
Cancer Gene Ther; 2002 Apr; 9(4):365-71. PubMed ID: 11960287
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):183-90. PubMed ID: 9171937
[TBL] [Abstract][Full Text] [Related]
6. Advances towards targetable adenovirus vectors for gene therapy.
Einfeld DA; Roelvink PW
Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.
Wickham TJ; Roelvink PW; Brough DE; Kovesdi I
Nat Biotechnol; 1996 Nov; 14(11):1570-3. PubMed ID: 9634823
[TBL] [Abstract][Full Text] [Related]
8. Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21.
Mailly L; Renaut L; Rogée S; Grellier E; D'Halluin JC; Colin M
Mol Ther; 2006 Aug; 14(2):293-304. PubMed ID: 16735140
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
10. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
[TBL] [Abstract][Full Text] [Related]
11. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
Rittner K; Schreiber V; Erbs P; Lusky M
Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
[TBL] [Abstract][Full Text] [Related]
12. Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies.
Särkioja M; Pesonen S; Raki M; Hakkarainen T; Salo J; Ahonen MT; Kanerva A; Hemminki A
Gene Ther; 2008 Jun; 15(12):921-9. PubMed ID: 18401431
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors.
Tanaka T; Huang J; Hirai S; Kuroki M; Kuroki M; Watanabe N; Tomihara K; Kato K; Hamada H
Clin Cancer Res; 2006 Jun; 12(12):3803-13. PubMed ID: 16778108
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
15. Modification of adenovirus type 5 tropism for a preferential transduction of human papillomavirus-positive cancer cells.
Lagrange M; Boulade-Ladame C; Orfanoudakis G; Deryckere F
Arch Virol; 2008; 153(10):1921-5. PubMed ID: 18726546
[TBL] [Abstract][Full Text] [Related]
16. Development of PEGylated adenovirus vector with targeting ligand.
Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer technologies for the gene therapy of cancer.
Vile R; Russell SJ
Gene Ther; 1994 Mar; 1(2):88-98. PubMed ID: 7584073
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
[TBL] [Abstract][Full Text] [Related]
19. Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma.
Shi W; Hemminki A; Bartlett JS
Gynecol Oncol; 2006 Dec; 103(3):1054-62. PubMed ID: 16870238
[TBL] [Abstract][Full Text] [Related]
20. Gene delivery by adenoviruses.
Franceschi RT; Ge C
Methods Mol Biol; 2008; 455():137-47. PubMed ID: 18463816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
